Oncology Practice Group Leaves Allegheny For Former Rival UPCI; Will NSABP Follow?
Cornell, MSKCC, Rockefeller To collaborate In $160M Basic Biological Research Program.
North General, MSK, Form Cancer Prevention Center.
Human Genome Consortium Completes “Working Draft”.
NCI Plans $40M In Grants For Cancer Outcomes Studies.
Reimbursement Of Some Anticancer Drugs Expected To Drop Sharply Under HHS Policy.
FDA Approves Large-Volume Processor For Cytyc’s ThinPrep Pap Test Samples.
Sustained-Release Leuprolide Under Study In Phase III Trial.
Celgene Signs CRADA With NCI For Development Of CDC-501.
Trending Stories
- Right-wing provocateur Laura Loomer comes for FDA’s Vinay Prasad
- FY25 paylines drop to 4th percentile—a historic low—as NCI braces for Trump’s FY26 budget cuts
- In the Headlines: Is oncology ready to move away from animal testing?
- Oncologist biotech entrepreneur George Tidmarsh joins FDA as CDER director
His appointment came out of “proximity” to Makary and Bhattacharya - Will MCD tests revolutionize cancer screening? NCI begins enrollment in Vanguard “feasibility” trial to start finding out
- Robert Winn: If Medicaid gets massive cuts or goes away, where will these patients get care?